Sign in
4

Changes in Ownership

Outlook Therapeutics, Inc. Filed Acc 0001209191-16-121073

Chief Medical Officer bought 2,000 shares

From the SEC's structured data for this filing

Trades in this filing

Bahrt Kenneth · Chief Medical Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2016-05-13 Purchase : show line 1 in the form +2,000 2,000 D
Open-market purchases · 2,000 sh

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2016-05-13 Purchase : show line 2 in the form Series A Warrants (right to buy) +1,000 $6.60 2017-02-18 1,000 1,000 D
2016-05-13 Purchase : show line 3 in the form Series B Warrants (right to buy) +1,000 $8.50 2018-05-18 1,000 1,000 D
Loading xslF345X03/doc4.xml…